Zobrazeno 1 - 5
of 5
pro vyhledávání: '"EG Krecko"'
Publikováno v:
Gene therapy. 5(5)
We have developed a method for generating high-titer retroviral producer cell lines conditionally containing a neomycin resistance gene (neo(r)) based on the Cre/loxP system. For this, a bicistronic retroviral splicing vector carrying the green fluor
Autor:
Wildner O; Clinical Gene Therapy Branch/National Human Genome Research Institute, National Institute of Health, Bethesda, MD 20892-1851, USA., Candotti F, Krecko EG, Xanthopoulos KG, Ramsey WJ, Blaese RM
Publikováno v:
Gene therapy [Gene Ther] 1998 May; Vol. 5 (5), pp. 684-91.
Autor:
Bonneville M; Howard Hughes Medical Institute, Center for Cancer Research, Cambridge, Massachusetts., Itohara S, Krecko EG, Mombaerts P, Ishida I, Katsuki M, Berns A, Farr AG, Janeway CA Jr, Tonegawa S
Publikováno v:
The Journal of experimental medicine [J Exp Med] 1990 Apr 01; Vol. 171 (4), pp. 1015-26.
Autor:
Ito K; Howard Hughes Medical Institute, Massachusetts Institute of Technology, Cambridge 02139., Bonneville M, Takagaki Y, Nakanishi N, Kanagawa O, Krecko EG, Tonegawa S
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 1989 Jan; Vol. 86 (2), pp. 631-5.
Autor:
Bonneville M; Howard Hughes Medical Institute, Massachusetts Institute of Technology, Cambridge, 02139., Ito K, Krecko EG, Itohara S, Kappes D, Ishida I, Kanagawa O, Janeway CA, Murphy DB, Tonegawa S
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 1989 Aug; Vol. 86 (15), pp. 5928-32.